NCT06894277

Brief Summary

Using the efficacious iTRAC intervention to enhance emotion regulation competencies as a foundation, this study will create and test iTRAC-HERO to teach emotion regulation skills in the context of sexual health education.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Apr 2025Aug 2026

First Submitted

Initial submission to the registry

February 26, 2025

Completed
27 days until next milestone

First Posted

Study publicly available on registry

March 25, 2025

Completed
7 days until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 8, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

February 26, 2025

Last Update Submit

March 30, 2026

Conditions

Keywords

Risky Sexual BehaviorEmotion RegulationAdolescent Behavior

Outcome Measures

Primary Outcomes (2)

  • Change in Sexual Self-Efficacy (SSE) from baseline to 6 months.

    The Sexual Self-Efficacy Scale (12 items) will measure self-efficacy for safer sexual activity as a main outcome which will indicate iTRAC-HERO's efficacy and ability to promote healthier sexual behaviors with the full sample (not just those who are sexually active).

    Baseline, 1 month post-intervention, 6 month follow up

  • Change in Self Efficacy for HIV Prevention from baseline to 6 month.

    The Self-Efficacy for HIV Prevention Scale (12 items) assesses a range of behaviors related to prevention of HIV, other STIs, or unintended pregnancy, including refusing sexual behaviors, discussing sexual histories with partners, buying condoms, taking free condoms, carrying condoms, and asking a partner to use a condom.

    Baseline, 1 month post-intervention, 6 month follow up

Secondary Outcomes (4)

  • Change in Sexual Risk Cognition from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

  • Change in attitudes towards abstinence from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

  • Change in frequency of sexual and substance use behaviors from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

  • Change in adolescent substance use behaviors from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

Other Outcomes (5)

  • Change in Emotion Regulation Skills from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

  • Change in frequency of dificulties with emotion regulation from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

  • Change in usage of emotion regulation behaviors taught in iTRAC-HERO from baseline to 6 months

    Baseline, 1 month post-intervention, 6 month follow up

  • +2 more other outcomes

Study Arms (2)

Waitlist Control

NO INTERVENTION

Control participants will be assessed on the same schedule as the treatment condition and offered the intervention after 6-month follow-up.

iTRAC-HERO

EXPERIMENTAL

iTRAC-HERO is an 8-module, web-based intervention for middle school boys and girls to complete. Its goal is primary prevention of adolescent sexual risk behaviors by targeting emotion regulation and sexual self-efficacy. (e.g., to refuse sexual advances).

Behavioral: iTRAC-HERO

Interventions

iTRAC-HEROBEHAVIORAL

iTRAC-HERO will consist of eight, approximately 45-minute, "gamified" digital modules of 4-6 activities (games, videos, etc.). No instruction is needed to use the program. Content will use gender- and sexuality-inclusive language and avoid heteronormative descriptions of risk. This content will include strategies for (and practice with) recognizing and managing emotions, particularly in relation to sexual health situations, to enhance the likelihood that the emotion regulation and sexual health education provided can be applied to experiences that are emotionally arousing and lead to risk.

iTRAC-HERO

Eligibility Criteria

Age12 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Attending 7th grade
  • Between 12 and 14 years old
  • Parent/guardian speaks English or Spanish
  • Attending participating school

You may not qualify if:

  • Unable to read at a 4th grade level
  • Have a sibling who has participated in the study
  • Have a development disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klein Buendel, Inc.

Golden, Colorado, 80401, United States

RECRUITING

MeSH Terms

Conditions

Emotional RegulationAdolescent Behavior

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Officials

  • Christopher Houck, PhD

    Rhode Island Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Waitlist Control Trial
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 26, 2025

First Posted

March 25, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

June 8, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

March 31, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

The investigators will prepare an archival-quality data package for upload to the National Institute of Child Health and Human Development (NICHD) Data and Specimen Hub (DASH). Specifically, the investigators will provide documentation on the full data-audit trail from the exact prompts seen by participants, to the syntax used to score and aggregate items, to the finalized data ready for use by qualified investigators. The archival-quality data package will also include a codebook in line with the Data Documentation Initiative (DDI) and contains information about variables, metadata, and file structure. The metadata will include description of the trial, including design, implementation, and description of the interventions. The intent is to provide everything that future investigators require to understand the trial, analyze the data, correctly interpret the findings, and be able to publish new analyses that meet current publication standards for clinical trials and/or meta-analyses.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
After analyses are completed for the aims of the study.
Access Criteria
The data package will be available for future investigators. For datasets that include potentially sensitive information, investigators not part of the original study will submit requests to be reviewed by the PIs. Qualified investigators who agree to terms of use and confidentiality agreements will be provided with deidentified data.

Locations